Continuing on Day 2 of this year’s SCOPE Summit in Orlando, a noteworthy session examined ways to better recognize and ...

Data from the largest patient-reported real-world data exploration underlines new opportunities for medical research to accelerate drug ...

Patient involvement is a concept covering the ways people can share their views and experiences to shape the healthcare ...

Melinda Bachini is the Chief Patient Officer at the Cholangiocarcinoma Foundation and a 15-year survivor of ...

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

A spokesperson for the Cholangiocarcinoma Foundation writes that experimental cancer trials saved her life and could save the ...

Laurie Adami's experience with CAR T-cell therapy highlights its potential in treating Non-Hodgkin Lymphoma, emphasizing the ...

Mariam F. Eskander, MD, MPH, and Coral O. Omene, MD, PhD, discuss how medical mistrust has impacted participation in oncology clinical trials.

In a survey, less than half of cancer patients and their family members said they were willing to participate in a clinical trial, and about a third of respondents said they had a positive perception ...

To “economically” weave the patient experience into the fabric of clinical trials, sponsors should consider two key factors: Although adapting to these two factors does take some ...